---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-041908"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:27:43.508138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Carmell raises $3.0M in private placement of 1.33M shares at $2.25-$2.88

## Summary
- Gross proceeds ~$3.0M before fees; 1,331,452 shares sold at $2.25 per share to investors and $2.88 to CEO.
- CEO participation at $2.88/share equal to April 3 closing price on Nasdaq.
- Proceeds for general corporate purposes; officers/directors subject to 90-day lock-up.
- Registration rights agreement to be filed within 30 days of closing covering resale of shares.
- Post-closing shares outstanding expected to be ~20.58 million.

## SEC filing metadata
- accession: 0000950170-24-041908
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/0000950170-24-041908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/ctcx-20240404.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-041908
- JSON: https://secwatch.observer/filing/0000950170-24-041908.json
- Plain text: https://secwatch.observer/filing/0000950170-24-041908.txt

## Key facts
- Material Agreements
  Longevity Health Holdings, Inc. entered into Purchase Agreement with certain investors named therein (the "Purchasers") valued at approximately $3.0 million (effective 2024-04-04).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors named therein (the "Purchasers")
  - Value: approximately $3.0 million
  - Effective: 2024-04-04
  source text: On April 4, 2024, Carmell Corporation, a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors named therein (the “Purchasers”) for the sale of an aggregate of 1,331,452 shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), at a price of $2.25 per share for unaffiliated investors and at a price of $2.88 per share for the Company’s Chief Executive Officer (the “Private Placement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/0000950170-24-041908-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.